Thyrocare Technologies

675.45
-15.95
(-2.31%)
Market Cap
3,579.33 Cr
EPS
13.42
PE Ratio
41.81
Dividend Yield
2.60 %
52 Week High
1,055.00
52 Week low
554.10
PB Ratio
7.51
Debt to Equity
0.06
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy100.00 %
100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,523.25 21,089.89 50.76 2,295.80 11.52 362 19.34 45.15
1,004.65 10,310.67 73.53 568.60 20.11 120 35.77 49.48
1,623.25 8,321.97 54.57 1,216.80 4.59 129 15.38 39.06
675.45 3,579.33 41.81 581.30 8.63 70 29.25 34.90
729.05 2,354.09 30.16 636.40 25.65 57 49.23 42.62
1,723.00 1,478.81 31.47 86.70 25.47 32 58.82 43.57
236.69 752.92 7.33 1,436.10 35.04 6 -1,081.25 44.26
277.95 197.39 17.55 63.00 248.07 7 133.33 45.37
127.00 88.44 70.71 36.90 6.34 1 0.00 53.32
84.50 87.00 100.21 13.60 -8.11 -3 142.86 71.89
Growth Rate
Revenue Growth
8.63 %
Net Income Growth
7.92 %
Cash Flow Change
29.63 %
ROE
9.57 %
ROCE
10.57 %
EBITDA Margin (Avg.)
5.21 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
56
63
55
67
72
81
74
89
93
92
88
108
99
107
100
108
112
119
107
104
58
158
141
151
175
191
119
133
129
137
131
140
136
151
138
158
161
180
170
Expenses
37
36
35
41
42
64
51
60
53
53
49
60
56
61
61
71
64
64
62
77
48
91
89
95
94
87
81
93
92
103
100
111
100
111
103
121
115
129
124
EBITDA
20
26
20
27
30
17
23
30
39
39
39
48
43
46
39
37
48
55
45
26
9
67
52
55
81
104
38
40
37
33
31
29
36
40
35
37
46
51
46
Operating Profit %
34 %
39 %
36 %
38 %
39 %
18 %
28 %
32 %
39 %
40 %
42 %
39 %
42 %
41 %
37 %
33 %
42 %
45 %
41 %
24 %
15 %
40 %
36 %
35 %
43 %
51 %
31 %
29 %
28 %
23 %
22 %
18 %
26 %
25 %
23 %
22 %
27 %
27 %
25 %
Depreciation
5
4
5
5
4
4
5
5
4
5
5
6
6
7
7
7
7
8
8
9
7
8
8
8
7
8
9
10
9
9
10
11
10
11
14
13
11
13
17
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
-0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Profit Before Tax
17
25
19
22
26
13
19
25
35
34
34
42
38
39
32
29
40
46
37
18
2
59
44
48
74
95
29
30
28
24
20
17
25
28
20
23
34
37
28
Tax
6
9
8
8
9
11
9
9
13
10
12
17
14
14
12
13
13
11
9
19
2
16
12
10
18
18
7
9
6
8
5
5
8
8
5
6
10
10
9
Net Profit
11
16
11
14
17
1
9
15
22
25
22
25
23
25
20
16
28
35
28
-2
0
43
32
38
56
78
22
21
22
15
15
13
17
20
15
17
24
26
19
EPS in ₹
2.33
3.28
2.13
2.71
3.18
0.22
1.71
2.90
4.10
4.59
4.03
4.68
4.35
4.70
3.81
3.09
5.20
6.73
5.21
-0.30
0.04
8.15
6.13
7.14
10.51
14.70
4.05
4.04
4.11
3.80
2.78
2.36
3.26
3.84
2.78
3.54
4.52
4.99
3.58

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
329
410
438
479
475
471
546
608
633
644
Fixed Assets
196
259
259
299
294
269
253
285
294
306
Current Assets
111
134
150
142
136
152
240
270
273
279
Capital Work in Progress
6
1
17
0
2
5
8
3
2
3
Investments
84
92
104
120
95
90
126
146
144
162
Other Assets
43
58
58
60
84
107
159
174
193
173
Total Liabilities
329
410
438
479
475
471
546
608
633
644
Current Liabilities
7
31
18
20
21
82
95
65
77
91
Non Current Liabilities
10
13
12
15
19
23
23
17
20
26
Total Equity
312
366
408
443
435
367
427
527
535
528
Reserve & Surplus
226
312
354
390
382
314
374
474
463
440
Share Capital
51
54
54
54
53
53
53
53
53
53

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-6
5
-1
-0
-5
4
5
0
4
-9
Investing Activities
-18
-18
-42
-43
-12
1
-49
-24
-39
-91
Operating Activities
35
68
90
107
100
168
115
113
129
168
Financing Activities
-23
-45
-49
-64
-94
-165
-62
-89
-86
-85

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
66.14 %
66.14 %
71.22 %
71.18 %
71.18 %
71.18 %
71.14 %
71.14 %
71.14 %
71.14 %
71.14 %
71.11 %
71.11 %
71.11 %
71.11 %
71.06 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.46 %
0.00 %
2.90 %
2.49 %
1.93 %
2.77 %
DIIs
7.14 %
6.17 %
6.07 %
6.37 %
6.52 %
6.68 %
8.66 %
8.69 %
8.45 %
13.46 %
13.33 %
13.55 %
14.88 %
14.90 %
14.80 %
14.67 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
5.01 %
6.32 %
7.60 %
7.44 %
6.65 %
6.71 %
7.28 %
8.07 %
8.38 %
9.42 %
9.66 %
9.15 %
8.48 %
8.66 %
9.78 %
9.16 %
Others
21.71 %
21.37 %
15.11 %
15.01 %
15.66 %
15.43 %
12.91 %
12.10 %
12.03 %
5.97 %
2.42 %
6.19 %
2.63 %
2.84 %
2.38 %
2.33 %
No of Share Holders
0
44,722
53,140
62,936
65,769
66,315
66,431
71,412
74,386
76,292
72,000
68,844
64,823
61,636
59,377
56,666

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 10 10 20 5 25 15 18 18 0.00
Dividend Yield (%) 0.00 1.68 1.87 4.03 0.55 3.22 3.56 3.05 2.6 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Acquisition
8 days ago
Integrated Filing (Financial)
Feb 03, 2025, 16:13
Updated Limited Review Report On The Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024
Feb 03, 2025, 16:04
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Jan 27, 2025, 16:26
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 25, 2025, 16:11
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jan 23, 2025, 18:59
Integrated Filing (Financial)
Jan 23, 2025, 18:33
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jan 23, 2025, 18:22
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Jan 23, 2025, 18:19
Appointment of Company Secretary and Compliance Officer
Jan 23, 2025, 18:16
Announcement under Regulation 30 (LODR)-Retirement
Jan 23, 2025, 18:13
Announcement under Regulation 30 (LODR)-Issue of Securities
Jan 23, 2025, 18:11
Financial Results For Quarter And Nine Months Ended December 31 2024
Jan 23, 2025, 18:08
Presentation on Un-audited Financial Results (Standalone and Consolidated) for the Quarter and nine months ended December 31 2024
Jan 23, 2025, 17:16
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 16, 2025, 20:26
Board Meeting Intimation for Considering And Approving Unaudited Standalone And Consolidated Financial Results For Quarter Ended December 31 2024.
Jan 16, 2025, 20:00
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 13, 2025, 17:19
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Jan 09, 2025, 21:07
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Jan 09, 2025, 21:03
Intimation Of Change In Name Of Registrar And Share Transfer Agent (RTA).
Jan 01, 2025, 11:29
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Dec 10, 2024, 16:29
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dec 10, 2024, 15:03
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Dec 09, 2024, 18:15
Disclosure Under Regulation 30 - Equity Infusion In Thyrocare Laboratories (Tanzania) Limited - Joint Venture
Dec 03, 2024, 23:25
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 06, 2024, 16:12
Disclosure under Regulation 30A of LODR
Oct 31, 2024, 12:56
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Oct 28, 2024, 17:11
Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 25, 2024, 19:39
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Oct 23, 2024, 21:45
Announcement under Regulation 30 (LODR)-Investor Presentation
Oct 23, 2024, 16:33
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Oct 23, 2024, 16:25
Financial Results For September 30, 2024
Oct 23, 2024, 16:20
Board Meeting Outcome for Outcome Of Board Meeting Held On October 23, 2024
Oct 23, 2024, 16:13
Re-Scheduling Of Invite For Earnings Conference Call
Oct 23, 2024, 12:43
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Oct 16, 2024, 18:31
Board Meeting Intimation for Considering And Approving The Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024.
Oct 16, 2024, 18:12
Completion Of Business Transfer Agreement With Vimta Labs Limited
Oct 11, 2024, 12:46
Closure of Trading Window
Sep 27, 2024, 18:09
Announcement under Regulation 30 (LODR)-Cessation
Sep 19, 2024, 12:18
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Aug 30, 2024, 11:38
Execution Of Business Transfer Agreement With Vimta Labs Limited.
Aug 30, 2024, 11:27
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Aug 27, 2024, 19:33
Shareholder Meeting / Postal Ballot-Outcome of AGM
Aug 23, 2024, 20:16
Announcement under Regulation 30 (LODR)-Cessation
Aug 19, 2024, 20:07
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 02, 2024, 19:09
Business Responsibility and Sustainability Reporting (BRSR)
Aug 01, 2024, 21:22
Corporate Action - Fixes Record For Dividend
Aug 01, 2024, 21:13
Reg. 34 (1) Annual Report.
Aug 01, 2024, 20:50
Notice Of 24Th Annual General Meeting Of The Company.
Aug 01, 2024, 20:42
Completion Of Business Transfer Agreement With Polo Labs Private Limited
Jul 29, 2024, 20:04

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
38.13
ATR(14)
Less Volatile
31.10
STOCH(9,6)
Neutral
46.35
STOCH RSI(14)
Overbought
88.32
MACD(12,26)
Bullish
3.84
ADX(14)
Weak Trend
20.66
UO(9)
Bearish
50.96
ROC(12)
Downtrend And Accelerating
-4.02
WillR(14)
Neutral
-56.79